Prevalence and description of skin reactions associated with adhesives in diabetes technology devices in an adult population: Results of the CUTADIAB study

Marc Diedisheim; Catherine Pecquet; Jean Baptiste Julla; Aurélie Carlier; Louis Potier; Agnès Hartemann; Sophie Jacqueminet; Tiphaine Vidal-Trecan; Jean François Gautier; Danièle Dubois-Laforgue; Guy Fagherazzi; Ronan Roussel; Etienne Larger; Agnès Sola-Gazagnes; Jean Pierre Riveline

doi:10.1016/j.mmm.2023.05.007

Prevalence and description of skin reactions associated with adhesives in diabetes technology devices in an adult population: Results of the CUTADIAB study

Marc Diedisheim, Catherine Pecquet, Jean Baptiste Julla, Aurélie Carlier, Louis Potier, Agnès Hartemann, Sophie Jacqueminet, Tiphaine Vidal-Trecan, Jean François Gautier, Danièle Dubois-Laforgue, Guy Fagherazzi, Ronan Roussel, Etienne Larger, Agnès Sola-Gazagnes, Jean Pierre Riveline^*

^*Corresponding author for this work

Research output: Contribution to journal › Short survey › peer-review

2 Citations (Scopus)

Abstract

The use of skin-adherent devices among patients with diabetes is on the rise. This multicenter French cross-sectional study evaluated the prevalence and consequences of skin reactions among 851 adult diabetic patients who used glucose sensors or insulin pumps in the last decade. Results showed that 28% of sensor users and 29% of pump users had skin reactions, occurring more frequently among women and patients with a history of eczema. Symptoms suggested skin irritation rather than an allergy. Skin reactions occurred within the first 24 hours in 22–24% of cases and after more than 6 months in 38% and 47% of cases for sensors and pumps, respectively. Finally, 12% of patients with a reaction to sensors and 7% of patients with a reaction to pumps discontinued using the device.

Original language	English
Pages (from-to)	326-334
Number of pages	9
Journal	Medecine des Maladies Metaboliques
Volume	17
Issue number	4
DOIs	https://doi.org/10.1016/j.mmm.2023.05.007
Publication status	Published - Jun 2023

Keywords

Allergy
Continuous blood glucose monitoring
France
Insulin pump
Sensors
Skin reaction
Subcutaneous insulin infusion

Access to Document

10.1016/j.mmm.2023.05.007

Cite this

Diedisheim, M., Pecquet, C., Julla, J. B., Carlier, A., Potier, L., Hartemann, A., Jacqueminet, S., Vidal-Trecan, T., Gautier, J. F., Dubois-Laforgue, D., Fagherazzi, G., Roussel, R., Larger, E., Sola-Gazagnes, A., & Riveline, J. P. (2023). Prevalence and description of skin reactions associated with adhesives in diabetes technology devices in an adult population: Results of the CUTADIAB study. Medecine des Maladies Metaboliques, 17(4), 326-334. https://doi.org/10.1016/j.mmm.2023.05.007

@article{ec1354d3d1b84b0db376c100ac56b5dc,

title = "Prevalence and description of skin reactions associated with adhesives in diabetes technology devices in an adult population: Results of the CUTADIAB study",

abstract = "The use of skin-adherent devices among patients with diabetes is on the rise. This multicenter French cross-sectional study evaluated the prevalence and consequences of skin reactions among 851 adult diabetic patients who used glucose sensors or insulin pumps in the last decade. Results showed that 28% of sensor users and 29% of pump users had skin reactions, occurring more frequently among women and patients with a history of eczema. Symptoms suggested skin irritation rather than an allergy. Skin reactions occurred within the first 24 hours in 22–24% of cases and after more than 6 months in 38% and 47% of cases for sensors and pumps, respectively. Finally, 12% of patients with a reaction to sensors and 7% of patients with a reaction to pumps discontinued using the device.",

keywords = "Allergy, Continuous blood glucose monitoring, France, Insulin pump, Sensors, Skin reaction, Subcutaneous insulin infusion",

author = "Marc Diedisheim and Catherine Pecquet and Julla, {Jean Baptiste} and Aur{\'e}lie Carlier and Louis Potier and Agn{\`e}s Hartemann and Sophie Jacqueminet and Tiphaine Vidal-Trecan and Gautier, {Jean Fran{\c c}ois} and Dani{\`e}le Dubois-Laforgue and Guy Fagherazzi and Ronan Roussel and Etienne Larger and Agn{\`e}s Sola-Gazagnes and Riveline, {Jean Pierre}",

note = "Funding Information: les auteurs tiennent {\`a} remercier l{\textquoteright}{\'e}quipe d'Eric Vicaut de l'Unit{\'e} de recherche clinique Fernand Widal pour le temps pris pour soumettre notre {\'e}tude au Comit{\'e} de protection des personnes sud-m{\'e}diterran{\'e}e. Financement cette recherche n{\textquoteright}a re{\c c}u aucune subvention sp{\'e}cifique d{\textquoteright}organismes de financement des secteurs public, commercial ou {\`a} but non lucratif. Les tablettes ont {\'e}t{\'e} fournies par l{\textquoteright}universit{\'e} Paris Cit{\'e}. Publisher Copyright: {\textcopyright} 2023 Elsevier Masson SAS",

year = "2023",

month = jun,

doi = "10.1016/j.mmm.2023.05.007",

language = "English",

volume = "17",

pages = "326--334",

journal = "Medecine des Maladies Metaboliques",

issn = "1957-2557",

publisher = "Elsevier Masson s.r.l.",

number = "4",

}

Diedisheim, M, Pecquet, C, Julla, JB, Carlier, A, Potier, L, Hartemann, A, Jacqueminet, S, Vidal-Trecan, T, Gautier, JF, Dubois-Laforgue, D, Fagherazzi, G, Roussel, R, Larger, E, Sola-Gazagnes, A & Riveline, JP 2023, 'Prevalence and description of skin reactions associated with adhesives in diabetes technology devices in an adult population: Results of the CUTADIAB study', Medecine des Maladies Metaboliques, vol. 17, no. 4, pp. 326-334. https://doi.org/10.1016/j.mmm.2023.05.007

Prevalence and description of skin reactions associated with adhesives in diabetes technology devices in an adult population: Results of the CUTADIAB study. / Diedisheim, Marc; Pecquet, Catherine; Julla, Jean Baptiste et al.
In: Medecine des Maladies Metaboliques, Vol. 17, No. 4, 06.2023, p. 326-334.

Research output: Contribution to journal › Short survey › peer-review

TY - JOUR

T1 - Prevalence and description of skin reactions associated with adhesives in diabetes technology devices in an adult population

T2 - Results of the CUTADIAB study

AU - Diedisheim, Marc

AU - Pecquet, Catherine

AU - Julla, Jean Baptiste

AU - Carlier, Aurélie

AU - Potier, Louis

AU - Hartemann, Agnès

AU - Jacqueminet, Sophie

AU - Vidal-Trecan, Tiphaine

AU - Gautier, Jean François

AU - Dubois-Laforgue, Danièle

AU - Fagherazzi, Guy

AU - Roussel, Ronan

AU - Larger, Etienne

AU - Sola-Gazagnes, Agnès

AU - Riveline, Jean Pierre

N1 - Funding Information: les auteurs tiennent à remercier l’équipe d'Eric Vicaut de l'Unité de recherche clinique Fernand Widal pour le temps pris pour soumettre notre étude au Comité de protection des personnes sud-méditerranée. Financement cette recherche n’a reçu aucune subvention spécifique d’organismes de financement des secteurs public, commercial ou à but non lucratif. Les tablettes ont été fournies par l’université Paris Cité. Publisher Copyright: © 2023 Elsevier Masson SAS

PY - 2023/6

Y1 - 2023/6

N2 - The use of skin-adherent devices among patients with diabetes is on the rise. This multicenter French cross-sectional study evaluated the prevalence and consequences of skin reactions among 851 adult diabetic patients who used glucose sensors or insulin pumps in the last decade. Results showed that 28% of sensor users and 29% of pump users had skin reactions, occurring more frequently among women and patients with a history of eczema. Symptoms suggested skin irritation rather than an allergy. Skin reactions occurred within the first 24 hours in 22–24% of cases and after more than 6 months in 38% and 47% of cases for sensors and pumps, respectively. Finally, 12% of patients with a reaction to sensors and 7% of patients with a reaction to pumps discontinued using the device.

AB - The use of skin-adherent devices among patients with diabetes is on the rise. This multicenter French cross-sectional study evaluated the prevalence and consequences of skin reactions among 851 adult diabetic patients who used glucose sensors or insulin pumps in the last decade. Results showed that 28% of sensor users and 29% of pump users had skin reactions, occurring more frequently among women and patients with a history of eczema. Symptoms suggested skin irritation rather than an allergy. Skin reactions occurred within the first 24 hours in 22–24% of cases and after more than 6 months in 38% and 47% of cases for sensors and pumps, respectively. Finally, 12% of patients with a reaction to sensors and 7% of patients with a reaction to pumps discontinued using the device.

KW - Allergy

KW - Continuous blood glucose monitoring

KW - France

KW - Insulin pump

KW - Sensors

KW - Skin reaction

KW - Subcutaneous insulin infusion

UR - http://www.scopus.com/inward/record.url?scp=85160037916&partnerID=8YFLogxK

U2 - 10.1016/j.mmm.2023.05.007

DO - 10.1016/j.mmm.2023.05.007

M3 - Short survey

AN - SCOPUS:85160037916

SN - 1957-2557

VL - 17

SP - 326

EP - 334

JO - Medecine des Maladies Metaboliques

JF - Medecine des Maladies Metaboliques

IS - 4

ER -

Prevalence and description of skin reactions associated with adhesives in diabetes technology devices in an adult population: Results of the CUTADIAB study

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this